E-LIB Suche - Ergebnisse für: Sutherland, Christina - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

An Automated, Open-Source Workflow for the Generation of (3..:

Dekker, Tom ; Janssen, Mathilde A. C. H ; Sutherland, Christina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184156/. , 2023

Link: http://www.ncbi.nlm.nih...

2

The Value and Institutional Impact of an In-System Laborato..:

Kaul, Karen ; Singh, Kamaljit ; Sabatini, Linda...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107259/. , 2021

Link: http://www.ncbi.nlm.nih...

3

Pharmacokinetics, Tissue Distribution, and Efficacy of VIO-..:

Petraitis, Vidmantas ; Petraitiene, Ruta ; Kavaliauskas, Povilas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522724/. , 2021

Link: http://www.ncbi.nlm.nih...

4

Development of an HPLC–MS/MS method for the determination o..:

Sutherland, Christina A ; Ozbal, Can ; Nicolau, David P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331755/. , 2018

Link: http://www.ncbi.nlm.nih...

5

2176. Single β-Lactams v. Combination Regimens: Assessing t..:

Sutherland, Christina ; Abuhussain, Safa Almarzoky ; Nicolau, David P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254472/. , 2018

Link: http://www.ncbi.nlm.nih...

6

2175. In vitro Potency of Ceftolozane/Tazobactam and Other ..:

Abuhussain, Safa Almarzoky ; Sutherland, Christina ; Nicolau, David P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253222/. , 2018

Link: http://www.ncbi.nlm.nih...

7

Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolo..:

Grupper, Mordechai ; Sutherland, Christina ; Nicolau, David P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610483/. , 2017

Link: http://www.ncbi.nlm.nih...

8

In vitro potency of amikacin and comparators against E. col..:

Sutherland, Christina ; Verastegui, Jamie ; Nicolau, David
http://www.ann-clinmicrob.com/content/15/1/39. , 2016

Link: http://www.ann-clinmicro..

9

In vitro Activity of Ceftolozane/Tazobactam Alone or with a..:

Dassner, Aimee M ; Sutherland, Christina ; Girotto, Jennifer.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336416/. , 2016

Link: http://www.ncbi.nlm.nih...

10

Impact of Revised Cefepime CLSI Breakpoints on Escherichia ..:

Hamada, Yukihiro ; Sutherland, Christina A ; Nicolau, David P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400738/. , 2015

Link: http://www.ncbi.nlm.nih...

11

To Add or Not To Add Polysorbate 80: Impact on Colistin MIC..:

Sutherland, Christina A ; Nicolau, David P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

12

415In Vitro Potency of Ceftolozane/Tazobactam against Pseud..:

Sutherland, Christina ; Nicolau, David
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781432/. , 2014

Link: http://www.ncbi.nlm.nih...

13

In Vitro Evaluation of Novel Compounds against Selected Res..:

Housman, Seth T ; Sutherland, Christina ; Nicolau, David P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294881. , 2012

Link: http://www.ncbi.nlm.nih...

14

In Vivo Comparison of CXA-101 (FR264205) with and without T..:

Bulik, Catharine C ; Tessier, Pamela R ; Keel, Rebecca A..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256089. , 2012

Link: http://www.ncbi.nlm.nih...

15

Comparison of the Activity of a Human Simulated, High-Dose,..:

Bulik, Catharine C ; Christensen, Henry ; Li, Peng...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812157. , 2010

Link: http://www.ncbi.nlm.nih...

1-15